AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Equipmake Holdings Plc

Declaration of Voting Results & Voting Rights Announcements Jan 27, 2023

6068_rns_2023-01-27_d696ac4b-4d64-4033-8e60-8ca1af50bec5.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1309O

Equipmake Holdings PLC

27 January 2023

Equipmake Holdings PLC

("Equipmake" or the "Company")

Result of Placing

Equipmake, the UK developer and manufacturer of electrification products for the provision of electric vehicle ("EV") drivetrains, is pleased to announce the completion of the Bookbuild, following the announcement of the Trading Update and Proposed Placing made by the Company earlier today. A total of 124,700,000 Placing Shares have been placed at a Placing Price of 5 pence per Placing Share to raise a total of £6.235 million for the Company (before expenses).

Application will be made for the Placing Shares to be admitted to trading on the Aquis Apex exchange. It is expected that dealings in the New Ordinary Shares in relation to the VCT Placing Shares will commence at 8:00 a.m. on 31 January 2023 ("First Admission") and dealings in the New Ordinary Shares in relation to the Non-VCT Placing Shares is expected to commence at 8:00 a.m. on 1 February 2023 ("Second Admission").

Upon First Admission, the Company will have 847,156,405 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company is therefore 847,156,405 and shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Upon Second Admission, the Company will have 948,229,409 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company is therefore 948,229,409 and shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules

Panmure Gordon acted as corporate adviser and joint broker and VSA acted as joint broker in connection with the Placing.

Defined terms used in this announcement not otherwise defined in this announcement are defined in the announcement of the Trading Update and Proposed Placing made by the Company earlier today.

For further information, please contact:

Equipmake

Ian Foley, Founder and CEO

Steven McGillivray, CFO
Via MHP
Panmure Gordon (Corporate Adviser & Joint Broker)

John Prior / James Sinclair-Ford / Freddie Twist (Corporate Finance)

Hugh Rich / Sam Elder (Corporate Broking)
Tel: +44 (0)20 7886 2500
VSA Capital Limited (Joint Broker)

Andrew Raca
Tel +44 (0)20 3005 5000
MHP (Financial PR Adviser)

Tim Rowntree

Eleni Menikou

Alan Tovey
Tel: +44 (0)20 3128 8100

[email protected]

This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR")). In addition, market soundings (as defined in UK MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in UK MAR), as permitted by UK MAR. This inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFDLFLXFLFBBX

Talk to a Data Expert

Have a question? We'll get back to you promptly.